However, there are no significant relationships between the CDH12 expression and other clinicopathologic features such as gender, age, tumor size, or lymph node metastasis (P>0.05) (Table 2). This evidence concerns the gene CDH12 and metastatic malignant neoplasm in the lymph nodes.